Algert Global LLC’s Xenon Pharmaceuticals Inc Position
Does Algert Global LLC own Xenon Pharmaceuticals Inc (XENE)? Yes — 264.2K shares worth $15M (+0.23% of its 13F portfolio) as of Q1 2026, up from 123.2K shares the prior filed quarter.
Position Value
$15M
Q1 2026
Shares
264.2K
% of Portfolio
+0.23%
Quarters Held
17
currently held
Position History XENE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 264.2K | $15M | +0.23% |
| Q4 2025 | 123.2K | $6M | +0.09% |
| Q3 2025 | 54.3K | $2M | +0.04% |
| Q2 2025 | 102.3K | $3M | +0.07% |
| Q1 2025 | 123.4K | $4M | +0.10% |
| Q4 2024 | 241.4K | $9M | +0.22% |
| Q3 2024 | 219.6K | $9M | +0.23% |
| Q2 2024 | 183.2K | $7M | +0.24% |
| Q1 2024 | 184.0K | $8M | +0.31% |
| Q4 2023 | 217.3K | $10M | +0.40% |
| Q3 2023 | 128.5K | $4M | +0.21% |
| Q2 2023 | 144.9K | $6M | +0.24% |
| Q1 2023 | 38.4K | $1M | +0.06% |
| Q4 2022 | 36.4K | $1M | +0.08% |
| Q3 2022 | 45.2K | $2M | +0.10% |
| Q2 2022 | 26.4K | $803,000 | +0.06% |
| Q1 2022 | 12.1K | $369,000 | +0.02% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Algert Global LLC’s full portfolio or all institutional holders of XENE.